SLV-154

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameSLV-154
Drug Alias NameSLV-154SLV 154
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerUterine Cervical NeoplasmsEndometrial Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSolve Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSolve Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerUterine Cervical NeoplasmsEndometrial Neoplasms +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A